Biological Information | |
---|---|
Background Information: | JQ1 is a chemical compound which is under development as a non-hormonal male contraceptive drug. Its chemical structure is a triazolothienodiazepine, a series originally discovered by Mitsubishi Pharma [WO/2009/084693], related to benzodiazepine derivatives such as etizolam, however JQ1 does not produce sedative or anxiolytic effects and is instead a potent and selective inhibitor of the bromodomain testis-specific protein BRDT, which is essential for chromatin remodeling during spermatogenesis. Provided as 1 mg of dry powder. |
Target Name: | JQ1 |
Usage | |
Product Type: | Control Ligands & Inhibitors |
Application: | Drug Discovery & Development |
Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
Additional Information | |
Brand: | DiscoverX |
(+)-JQ1
![Awaiting product image](https://www.discoverx.com/content/uploads/2023/08/edx-default.jpg)
(+)-JQ1 is an antagonist for BRDT. This product is provided as 1 mg of dry powder.
Datasheets
92-1149 Datasheet
View Document